First human test of new lung disease inhaler begins
NCT ID NCT07267130
Summary
This is an early safety study for a new inhaler called TQC3302, which is being developed for Chronic Obstructive Pulmonary Disease (COPD). Researchers are testing it in 57 healthy adults to see how safe it is, how well it is tolerated, and how the body processes the drug. The main goal is to understand the drug's side effects and how it moves through the bloodstream after being inhaled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China Japan Friendship Hospital Beijing
RECRUITINGBeijing, Beijing Municipality, 100000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.